Conference Coverage
Conference Coverage
Psoriasis Patients Still Going Unscreened for Heart Disease
Major Finding: Approximately 41% of psoriasis patients were screened for at least one of four risk factors for cardiovascular disease during...
Conference Coverage
Collagenase Might Be a First-Line Treatment for Dupuytren's Contractures
Major Finding: The first injection of collagenase C. histolyticum into palpable cords of Dupuytren’s contracture resulted in a mean 81% reduction...
Conference Coverage
Meta-Analysis Shows 75% Increased Risk Herpes Zoster With Anti-TNF
Major finding: Compared with patients on DMARDs, the risk of herpes zoster in patients on anti-TNF inhibitors has an odds ratio of 1.75. Data...
Conference Coverage
Clinical Trials May Overestimate Benefits of Psoriasis Drugs
Conference Coverage
Psoriatic Arthritis Screening Tests Deemed Inadequate
Major Finding: Three popular screening tests for psoriatic arthritis in patients with psoriasis displayed suboptimal specificities of 45%-55% in a...
Conference Coverage
Tocilizumab Beats Adalimumab in Monotherapy RA Trial
Conference Coverage
Ixekizumab Normalizes Mutant Psoriasis Genes
Major Finding: Ixekizumab resulted in a greater-than-75% normalization of expression of 643 inflammatory genes, compared with 104 with etanercept...
Conference Coverage
Certolizumab Eased Skin and Joint Symptoms in PsA
Major Finding: An ACR 20 response at 12 weeks was documented in 58% of PsA patients who were randomized to the pegylated TNF inhibitor...
Conference Coverage
Stem Cell Transplant Boosts Survival in Scleroderma
Major Finding: Death or persistent major organ failure during an average 7 years of follow-up occurred in 19 patients with poor-prognosis diffuse...
Conference Coverage
Rosuvastatin Lessened Endothelial Dysfunction in SSc
Major finding: Rosuvastatin increased low-mediated dilatation in systemic sclerosis from 2.3% to 5.7%.Data source: The data come from a case-...